CAS: 74784-45-5 - [[(2R,3S,4S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3R,4S,5R)-5-[(4R)-3-carbamoyl-4-deuterio-4H-pyridin-1-yl]-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate
Formel:C21H29DN7O17P3
InChl:InChI=1/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13+,14+,15+,16+,20-,21-/m1/s1/i2D/t2-,10-,11-,13+,14+,15+,16+,20-,21-
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
b-Nicotinamide-D adenine dinucleotide reduced form REF: 7W-GN8620CAS: 74784-45-5 | - - - | Nachfragen | Do 05 Dez 24 | |
β-NADPH-D REF: 4Z-N-076001CAS: 74784-45-5 | - - - | Nachfragen | Mi 11 Dez 24 | |
b-Nicotinamide-D adenine dinucleotide reduced form REF: 3D-NN11407CAS: 74784-45-5 | Min. 95% | Nachfragen | Mi 15 Jan 25 |
Ref: 7W-GN8620
Unbestimmte Größe | Nachfragen |
Ref: 4Z-N-076001
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
b-Nicotinamide-D adenine dinucleotide reduced form
Ref: 3D-NN11407
1mg | Nachfragen | ||
5mg | Nachfragen | ||
10mg | Nachfragen |